Macclesfield, United Kingdom

Philip John Jewsbury

This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip John Jewsbury. Retrieved from https://idiyas.com/inventor/philip-john-jewsbury

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Philip John Jewsbury

Introduction

Philip John Jewsbury is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that may aid in cancer treatment. With a total of 2 patents, his work continues to impact the scientific community.

Latest Patents

Jewsbury's latest patent focuses on Piperizine-4-phenyl derivatives as inhibitors of the interaction between MDM2 and p53. This compound, defined by a specific formula, includes various substituents that enhance its efficacy. The compounds are designed to inhibit the interactions between MDM2 and p53, which may be beneficial in treating cancers.

Career Highlights

Philip John Jewsbury is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in the medical field. His research and inventions are crucial in the ongoing battle against cancer.

Collaborations

Jewsbury has collaborated with esteemed colleagues such as Gloria Anne Breault and Janet Elizabeth Pease. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Philip John Jewsbury's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…